87 related articles for article (PubMed ID: 34608826)
1. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
You Y; Que K; Zhou Y; Zhang Z; Zhao X; Gong J; Liu Z
Mol Cells; 2018 Sep; 41(9):830-841. PubMed ID: 30145863
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
[TBL] [Abstract][Full Text] [Related]
4. The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features.
Qi X; Liu L
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102273. PubMed ID: 38145786
[TBL] [Abstract][Full Text] [Related]
5. Role of miR
Cao Z; Zeng L; Wang Z; Zhou Y; Qian K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1281-1295. PubMed ID: 38044639
[TBL] [Abstract][Full Text] [Related]
6. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.
ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE
Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165
[TBL] [Abstract][Full Text] [Related]
7. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
[TBL] [Abstract][Full Text] [Related]
8. MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation.
Qian F; Wang J; Wang Y; Gao Q; Yan W; Lin Y; Shen L; Xie Y; Jiang X; Shen B
Clin Transl Med; 2021 Feb; 11(2):e307. PubMed ID: 33634974
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
Yuan X; Wen Y; Shi Q; Zhao Y; Ding J
Biochem Biophys Res Commun; 2024 Feb; 695():149424. PubMed ID: 38169186
[TBL] [Abstract][Full Text] [Related]
10. Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
Huang H; Lan C; Wei Y; Nong J; Liao X; Ye X; Deng G; Peng T; Zhou X
Aging (Albany NY); 2024 Mar; 16(7):6229-6261. PubMed ID: 38552222
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2.
Wang Y; Chang W; Chang W; Chang X; Zhai S; Pan G; Dang S
J Cancer; 2018; 9(22):4187-4196. PubMed ID: 30519319
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
Wang X; Lu J; Cao J; Ma B; Gao C; Qi F
Onco Targets Ther; 2018; 11():7919-7934. PubMed ID: 30519035
[TBL] [Abstract][Full Text] [Related]
13. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Coulouarn C; Factor VM; Andersen JB; Durkin ME; Thorgeirsson SS
Oncogene; 2009 Oct; 28(40):3526-36. PubMed ID: 19617899
[TBL] [Abstract][Full Text] [Related]
14. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of LINC01132 in lung cancer and its regulatory role in tumor progression.
Hu Y; Wei Y
Discov Oncol; 2024 Feb; 15(1):49. PubMed ID: 38403680
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance and Functional Insights of Tesmin in Hepatocellular Carcinoma.
Cao L; Zhang L; Liu S; Wang X
Genet Res (Camb); 2024; 2024():3058875. PubMed ID: 38283987
[TBL] [Abstract][Full Text] [Related]
17. MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis.
He G; Qiu J; Liu C; Tian B; Cai D; Liu S
Front Oncol; 2021; 11():625566. PubMed ID: 35004265
[TBL] [Abstract][Full Text] [Related]
18. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
Xie Z; Hao Q; Zhu R; Ma R
Can J Gastroenterol Hepatol; 2024; 2024():2211179. PubMed ID: 38529202
[TBL] [Abstract][Full Text] [Related]
19. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism.
Gao H; Gao Z; Liu X; Sun X; Hu Z; Song Z; Zhang C; Fei J; Wang X
Cell Div; 2024 Mar; 19(1):9. PubMed ID: 38532426
[TBL] [Abstract][Full Text] [Related]
20. Rho GTPase-activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR-101-3p.
Xu Y; Liu X; Cao J; Wu Y; Jiang Q; Luo B
Hepatol Res; 2024 Feb; 54(2):174-188. PubMed ID: 37792600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
